Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 970

1.

Brain Radiation Necrosis: Current Management With a Focus on Non-small Cell Lung Cancer Patients.

Loganadane G, Dhermain F, Louvel G, Kauv P, Deutsch E, Le Péchoux C, Levy A.

Front Oncol. 2018 Sep 5;8:336. doi: 10.3389/fonc.2018.00336. eCollection 2018. Review.

2.

Flexible and fast mapping of peptides to a proteome with ProteoMapper.

Mendoza L, Deutsch EW, Sun Z, Campbell DS, Shteynberg DD, Moritz RL.

J Proteome Res. 2018 Sep 19. doi: 10.1021/acs.jproteome.8b00544. [Epub ahead of print]

PMID:
30230343
3.

AGuIX® from bench to bedside-Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine.

Lux F, Tran VL, Thomas E, Dufort S, Rossetti F, Martini M, Truillet C, Doussineau T, Bort G, Denat F, Boschetti F, Angelovski G, Detappe A, Crémillieux Y, Mignet N, Doan BT, Larrat B, Meriaux S, Barbier E, Roux S, Fries P, Müller A, Abadjian MC, Anderson C, Canet-Soulas E, Bouziotis P, Barberi-Heyob M, Frochot C, Verry C, Balosso J, Evans M, Sidi-Boumedine J, Janier M, Butterworth K, McMahon S, Prise K, Aloy MT, Ardail D, Rodriguez-Lafrasse C, Porcel E, Lacombe S, Berbeco R, Allouch A, Perfettini JL, Chargari C, Deutsch E, Le Duc G, Tillement O.

Br J Radiol. 2018 Sep 18:20180365. doi: 10.1259/bjr.20180365. [Epub ahead of print]

PMID:
30226413
4.

Combining radiation therapy and cancer immune therapies: From preclinical findings to clinical applications.

Bockel S, Durand B, Deutsch E.

Cancer Radiother. 2018 Oct;22(6-7):567-580. doi: 10.1016/j.canrad.2018.07.136. Epub 2018 Sep 6.

PMID:
30197026
5.

Influence of tumor-associated macrophages and HLA class I expression according to HPV status in head and neck cancer patients receiving chemo/bioradiotherapy.

Ou D, Adam J, Garberis I, Blanchard P, Nguyen F, Levy A, Casiraghi O, Gorphe P, Breuskin I, Janot F, Temam S, Scoazec JY, Deutsch E, Tao Y.

Radiother Oncol. 2018 Aug 29. pii: S0167-8140(18)33451-0. doi: 10.1016/j.radonc.2018.08.013. [Epub ahead of print]

PMID:
30172455
6.

A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.

Sun R, Limkin EJ, Vakalopoulou M, Dercle L, Champiat S, Han SR, Verlingue L, Brandao D, Lancia A, Ammari S, Hollebecque A, Scoazec JY, Marabelle A, Massard C, Soria JC, Robert C, Paragios N, Deutsch E, Ferté C.

Lancet Oncol. 2018 Sep;19(9):1180-1191. doi: 10.1016/S1470-2045(18)30413-3. Epub 2018 Aug 14.

PMID:
30120041
7.

Progress on Identifying and Characterizing the Human Proteome: 2018 Metrics from the HUPO Human Proteome Project.

Omenn GS, Lane L, Overall CM, Corrales FJ, Schwenk JM, Paik YK, Van Eyk JE, Liu S, Snyder M, Baker MS, Deutsch EW.

J Proteome Res. 2018 Aug 23. doi: 10.1021/acs.jproteome.8b00441. [Epub ahead of print]

PMID:
30099871
8.

A tissue-based draft map of the murine MHC class I immunopeptidome.

Schuster H, Shao W, Weiss T, Pedrioli PGA, Roth P, Weller M, Campbell DS, Deutsch EW, Moritz RL, Planz O, Rammensee HG, Aebersold R, Caron E.

Sci Data. 2018 Aug 7;5:180157. doi: 10.1038/sdata.2018.157.

9.

[Editorial].

Deutsch E; Le groupe TEP-RT.

Cancer Radiother. 2018 Sep;22(5):383. doi: 10.1016/j.canrad.2018.07.009. Epub 2018 Aug 3. French. No abstract available.

PMID:
30082201
10.

[Radiation therapy planning for Hodgkin lymphoma: Focus on intensity-modulated radiotherapy, gating, protons. Which techniques to best deliver radiation?]

Boros A, Ribrag V, Deutsch É, Chargari C, Izar F.

Cancer Radiother. 2018 Sep;22(5):404-410. doi: 10.1016/j.canrad.2018.07.007. Epub 2018 Jul 31. Review. French.

PMID:
30076071
11.

Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy.

Schernberg A, Blanchard P, Chargari C, Ou D, Levy A, Gorphe P, Breuskin I, Atallah S, Caula A, Escande A, Janot F, Nguyen F, Temam S, Deutsch E, Tao Y.

Clin Transl Radiat Oncol. 2018 Jul 6;12:8-15. doi: 10.1016/j.ctro.2018.07.002. eCollection 2018 Aug.

12.

Radiomics in Nuclear Medicine Applied to Radiation Therapy: Methods, Pitfalls, and Challenges.

Reuzé S, Schernberg A, Orlhac F, Sun R, Chargari C, Dercle L, Deutsch E, Buvat I, Robert C.

Int J Radiat Oncol Biol Phys. 2018 May 22. pii: S0360-3016(18)30815-0. doi: 10.1016/j.ijrobp.2018.05.022. [Epub ahead of print]

PMID:
30064704
13.

Neutrophilia as a biomarker for overall survival in newly diagnosed high-grade glioma patients undergoing chemoradiation.

Schernberg A, Nivet A, Dhermain F, Ammari S, Escande A, Pallud J, Louvel G, Deutsch E.

Clin Transl Radiat Oncol. 2018 Apr 13;10:47-52. doi: 10.1016/j.ctro.2018.04.002. eCollection 2018 Mar.

14.

Tumor Shrinkage During Chemoradiation in Locally Advanced Cervical Cancer Patients: Prognostic Significance, and Impact for Image-Guided Adaptive Brachytherapy.

Schernberg A, Bockel S, Annede P, Fumagalli I, Escande A, Mignot F, Kissel M, Morice P, Bentivegna E, Gouy S, Deutsch E, Haie-Meder C, Chargari C.

Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):362-372. doi: 10.1016/j.ijrobp.2018.06.014. Epub 2018 Jun 18.

PMID:
29920324
15.

Anticancer chemotherapy and radiotherapy trigger both non-cell-autonomous and cell-autonomous death.

Martins I, Raza SQ, Voisin L, Dakhli H, Allouch A, Law F, Sabino D, De Jong D, Thoreau M, Mintet E, Dugué D, Piacentini M, Gougeon ML, Jaulin F, Bertrand P, Brenner C, Ojcius DM, Kroemer G, Modjtahedi N, Deutsch E, Perfettini JL.

Cell Death Dis. 2018 Jun 18;9(7):716. doi: 10.1038/s41419-018-0747-y.

16.

"Radiobiology of Proton Therapy": Results of an international expert workshop.

Lühr A, von Neubeck C, Pawelke J, Seidlitz A, Peitzsch C, Bentzen SM, Bortfeld T, Debus J, Deutsch E, Langendijk JA, Loeffler JS, Mohan R, Scholz M, Sørensen BS, Weber DC, Baumann M, Krause M; “Radiobiology of Proton Therapy”.

Radiother Oncol. 2018 Jul;128(1):56-67. doi: 10.1016/j.radonc.2018.05.018. Epub 2018 Jun 1. Review.

PMID:
29861141
17.

Radiobiology of brachytherapy: The historical view based on linear quadratic model and perspectives for optimization.

Chargari C, Van Limbergen E, Mahantshetty U, Deutsch É, Haie-Méder C.

Cancer Radiother. 2018 Jun;22(4):312-318. doi: 10.1016/j.canrad.2017.11.011. Epub 2018 May 30. Review.

PMID:
29858137
18.

Pharmacological modulation of radiation-induced oral mucosal complications.

Bockel S, Vallard A, Lévy A, François S, Bourdis M, Le Gallic C, Riccobono D, Annede P, Drouet M, Tao Y, Blanchard P, Deutsch É, Magné N, Chargari C.

Cancer Radiother. 2018 Sep;22(5):429-437. doi: 10.1016/j.canrad.2017.11.006. Epub 2018 May 26. Review.

PMID:
29776830
19.

Risk of Late Urinary Complications Following Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: Refining Bladder Dose-Volume Parameters.

Manea E, Escande A, Bockel S, Khettab M, Dumas I, Lazarescu I, Fumagalli I, Morice P, Deutsch E, Haie-Meder C, Chargari C.

Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):411-420. doi: 10.1016/j.ijrobp.2018.02.004. Epub 2018 Feb 13.

PMID:
29559282
20.

Staying Well in a Sea of Harm.

Deutsch ES.

Otolaryngol Head Neck Surg. 2018 Jun;158(6):983-984. doi: 10.1177/0194599818764409. Epub 2018 Mar 13.

PMID:
29533701
21.

Locally advanced cervical cancer with bladder invasion: clinical outcomes and predictive factors for vesicovaginal fistulae.

Sun R, Koubaa I, Limkin EJ, Dumas I, Bentivegna E, Castanon E, Gouy S, Baratiny C, Monnot F, Maroun P, Ammari S, Zareski E, Balleyguier C, Deutsch É, Morice P, Haie-Meder C, Chargari C.

Oncotarget. 2018 Jan 18;9(10):9299-9310. doi: 10.18632/oncotarget.24271. eCollection 2018 Feb 6.

22.

Wrong-site nerve blocks: A systematic literature review to guide principles for prevention.

Deutsch ES, Yonash RA, Martin DE, Atkins JH, Arnold TV, Hunt CM.

J Clin Anesth. 2018 May;46:101-111. doi: 10.1016/j.jclinane.2017.12.008. Epub 2018 Mar 2. Review.

PMID:
29505959
23.

CSF1R inhibition prevents radiation pulmonary fibrosis by depletion of interstitial macrophages.

Meziani L, Mondini M, Petit B, Boissonnas A, Thomas de Montpreville V, Mercier O, Vozenin MC, Deutsch E.

Eur Respir J. 2018 Mar 1;51(3). pii: 1702120. doi: 10.1183/13993003.02120-2017. Print 2018 Mar.

PMID:
29496785
24.

Monitoring water quality in a hypereutrophic reservoir using Landsat ETM+ and OLI sensors: how transferable are the water quality algorithms?

Deutsch ES, Alameddine I, El-Fadel M.

Environ Monit Assess. 2018 Feb 15;190(3):141. doi: 10.1007/s10661-018-6506-9.

PMID:
29450661
25.

Human epidermal receptor family inhibitors in patients with ERBB3 mutated cancers: Entering the back door.

Verlingue L, Hollebecque A, Lacroix L, Postel-Vinay S, Varga A, El Dakdouki Y, Baldini C, Balheda R, Gazzah A, Michot JM, Marabelle A, Mir O, Arnedos M, Rouleau E, Solary E, De Baere T, Angevin E, Armand JP, Michiels S, André F, Deutsch E, Scoazec JY, Soria JC, Massard C.

Eur J Cancer. 2018 Mar;92:1-10. doi: 10.1016/j.ejca.2017.12.020. Epub 2018 Feb 3.

PMID:
29413684
26.

The proBAM and proBed standard formats: enabling a seamless integration of genomics and proteomics data.

Menschaert G, Wang X, Jones AR, Ghali F, Fenyö D, Olexiouk V, Zhang B, Deutsch EW, Ternent T, Vizcaíno JA.

Genome Biol. 2018 Jan 31;19(1):12. doi: 10.1186/s13059-017-1377-x.

27.

Multiple Mycotic Visceral Artery Aneurysms.

Naveed MZ, Joshi A, Deutsch E.

Am Surg. 2017 Dec 1;83(12):e482-484. No abstract available.

PMID:
29336743
28.

Transcriptional response to hypoxic stress in melanoma and prognostic potential of GBE1 and BNIP3.

Buart S, Terry S, Noman MZ, Lanoy E, Boutros C, Fogel P, Dessen P, Meurice G, Gaston-Mathé Y, Vielh P, Roy S, Routier E, Marty V, Ferlicot S, Legrès L, Bouchtaoui ME, Kamsu-Kom N, Muret J, Deutsch E, Eggermont A, Soria JC, Robert C, Chouaib S.

Oncotarget. 2017 Oct 30;8(65):108786-108801. doi: 10.18632/oncotarget.22150. eCollection 2017 Dec 12.

29.

Concerns about cardiotoxicity in the HERA trial.

Levy A, Chargari C, Deutsch E, Rivera S.

Lancet. 2018 Dec 23;390(10114):2767. doi: 10.1016/S0140-6736(17)31954-2. No abstract available.

PMID:
29303721
30.

Immunotherapy and pulmonary toxicities: can concomitant immune-checkpoint inhibitors with radiotherapy increase the risk of radiation pneumonitis?

Louvel G, Bahleda R, Ammari S, Le Péchoux C, Levy A, Massard C, Le Pavec J, Champiat S, Deutsch E.

Eur Respir J. 2018 Jan 4;51(1). pii: 1701737. doi: 10.1183/13993003.01737-2017. Print 2018 Jan. No abstract available.

PMID:
29301923
31.

Anti-PD-1 Vasculitis of the central nervous system or radionecrosis?

Sun R, Danlos FX, Ammari S, Louvel G, Dhermain F, Champiat S, Lambotte O, Deutsch E.

J Immunother Cancer. 2017 Dec 19;5(1):96. doi: 10.1186/s40425-017-0304-8.

32.

Mapping genetic variations to three-dimensional protein structures to enhance variant interpretation: a proposed framework.

Glusman G, Rose PW, Prlić A, Dougherty J, Duarte JM, Hoffman AS, Barton GJ, Bendixen E, Bergquist T, Bock C, Brunk E, Buljan M, Burley SK, Cai B, Carter H, Gao J, Godzik A, Heuer M, Hicks M, Hrabe T, Karchin R, Leman JK, Lane L, Masica DL, Mooney SD, Moult J, Omenn GS, Pearl F, Pejaver V, Reynolds SM, Rokem A, Schwede T, Song S, Tilgner H, Valasatava Y, Zhang Y, Deutsch EW.

Genome Med. 2017 Dec 18;9(1):113. doi: 10.1186/s13073-017-0509-y. Review.

33.

Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients.

Schernberg A, Dhermain F, Ammari S, Dumont SN, Domont J, Patrikidou A, Pallud J, Dezamis É, Deutsch É, Louvel G.

Cancer Radiother. 2018 Feb;22(1):9-16. doi: 10.1016/j.canrad.2017.06.013. Epub 2017 Dec 6.

PMID:
29217134
34.

Progress and Future Direction of Chromosome-Centric Human Proteome Project.

Paik YK, Overall CM, Deutsch EW, Van Eyk JE, Omenn GS.

J Proteome Res. 2017 Dec 1;16(12):4253-4258. doi: 10.1021/acs.jproteome.7b00734.

PMID:
29191025
35.

Brachytherapy for conservative treatment of invasive penile carcinoma in older patients: Single institution experience.

Escande A, Maroun P, Dumas I, Schernberg A, Bossi A, De Crevoisier R, Deutsch E, Haie-Meder C, Chargari C.

J Geriatr Oncol. 2018 May;9(3):275-278. doi: 10.1016/j.jgo.2017.11.001. Epub 2017 Nov 21.

PMID:
29170049
36.

Bimodal fluorescence/129Xe NMR probe for molecular imaging and biological inhibition of EGFR in Non-Small Cell Lung Cancer.

Milanole G, Gao B, Paoletti A, Pieters G, Dugave C, Deutsch E, Rivera S, Law F, Perfettini JL, Mari E, Léonce E, Boutin C, Berthault P, Volland H, Fenaille F, Brotin T, Rousseau B.

Bioorg Med Chem. 2017 Dec 15;25(24):6653-6660. doi: 10.1016/j.bmc.2017.11.002. Epub 2017 Nov 6.

PMID:
29150078
37.

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.

Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, Fidelle M, Flament C, Poirier-Colame V, Opolon P, Klein C, Iribarren K, Mondragón L, Jacquelot N, Qu B, Ferrere G, Clémenson C, Mezquita L, Masip JR, Naltet C, Brosseau S, Kaderbhai C, Richard C, Rizvi H, Levenez F, Galleron N, Quinquis B, Pons N, Ryffel B, Minard-Colin V, Gonin P, Soria JC, Deutsch E, Loriot Y, Ghiringhelli F, Zalcman G, Goldwasser F, Escudier B, Hellmann MD, Eggermont A, Raoult D, Albiges L, Kroemer G, Zitvogel L.

Science. 2018 Jan 5;359(6371):91-97. doi: 10.1126/science.aan3706. Epub 2017 Nov 2.

PMID:
29097494
38.

Phase I trial of bortezomib daily dose: safety, pharmacokinetic profile, biological effects and early clinical evaluation in patients with advanced solid tumors.

Bahleda R, Le Deley MC, Bernard A, Chaturvedi S, Hanley M, Poterie A, Gazzah A, Varga A, Touat M, Deutsch E, Massard C, Van De Velde H, Hollebecque A, Sallansonnet-Froment M, Ricard D, Taillia H, Angevin E, Ribrag V, Soria JC.

Invest New Drugs. 2018 Aug;36(4):619-628. doi: 10.1007/s10637-017-0531-3. Epub 2017 Nov 2.

PMID:
29094232
39.

Long-term evaluation of urinary, sexual, and quality of life outcomes after brachytherapy for penile carcinoma.

Gambachidze D, Lebacle C, Maroun P, Escande A, Bossi A, Blanchard P, Deutsch E, Haie-Meder C, Chargari C.

Brachytherapy. 2018 Jan - Feb;17(1):221-226. doi: 10.1016/j.brachy.2017.09.006. Epub 2017 Oct 28.

PMID:
29089276
40.

Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy.

Ou D, Garberis I, Adam J, Blanchard P, Nguyen F, Levy A, Casiraghi O, Gorphe P, Breuskin I, Janot F, Temam S, Scoazec JY, Deutsch E, Tao Y.

Radiother Oncol. 2018 Jan;126(1):116-124. doi: 10.1016/j.radonc.2017.10.007. Epub 2017 Nov 1.

PMID:
29079308
41.

Navigating the highlights of phase III trials: a watchful eye on evidence-based radiotherapy.

Trone JC, Espenel S, Rehailia-Blanchard A, Guillaume E, Vial N, Rancoule C, Rodriguez-Lafrasse C, Ben Mrad M, El Meddeb Hamrouni A, Ollier E, Chargari C, Deutsch E, Vallard A, Magné N.

Ann Oncol. 2017 Nov 1;28(11):2691-2697. doi: 10.1093/annonc/mdx347. Review.

PMID:
29045516
42.

The SysteMHC Atlas project.

Shao W, Pedrioli PGA, Wolski W, Scurtescu C, Schmid E, Vizcaíno JA, Courcelles M, Schuster H, Kowalewski D, Marino F, Arlehamn CSL, Vaughan K, Peters B, Sette A, Ottenhoff THM, Meijgaarden KE, Nieuwenhuizen N, Kaufmann SHE, Schlapbach R, Castle JC, Nesvizhskii AI, Nielsen M, Deutsch EW, Campbell DS, Moritz RL, Zubarev RA, Ytterberg AJ, Purcell AW, Marcilla M, Paradela A, Wang Q, Costello CE, Ternette N, van Veelen PA, van Els CACM, Heck AJR, de Souza GA, Sollid LM, Admon A, Stevanovic S, Rammensee HG, Thibault P, Perreault C, Bassani-Sternberg M, Aebersold R, Caron E.

Nucleic Acids Res. 2018 Jan 4;46(D1):D1237-D1247. doi: 10.1093/nar/gkx664.

43.

The Human Plasma Proteome Draft of 2017: Building on the Human Plasma PeptideAtlas from Mass Spectrometry and Complementary Assays.

Schwenk JM, Omenn GS, Sun Z, Campbell DS, Baker MS, Overall CM, Aebersold R, Moritz RL, Deutsch EW.

J Proteome Res. 2017 Dec 1;16(12):4299-4310. doi: 10.1021/acs.jproteome.7b00467. Epub 2017 Oct 10.

44.

Clinical relevance of tumor infiltrating lymphocytes, PD-L1 expression and correlation with HPV/p16 in head and neck cancer treated with bio- or chemo-radiotherapy.

Ou D, Adam J, Garberis I, Blanchard P, Nguyen F, Levy A, Casiraghi O, Gorphe P, Breuskin I, Janot F, Temam S, Scoazec JY, Deutsch E, Tao Y.

Oncoimmunology. 2017 Jul 5;6(9):e1341030. doi: 10.1080/2162402X.2017.1341030. eCollection 2017.

45.

Macrophage biology plays a central role during ionizing radiation-elicited tumor response.

Wu Q, Allouch A, Martins I, Modjtahedi N, Deutsch E, Perfettini JL.

Biomed J. 2017 Aug;40(4):200-211. doi: 10.1016/j.bj.2017.06.003. Epub 2017 Jul 29. Review.

46.

A score combining baseline neutrophilia and primary tumor SUVpeak measured from FDG PET is associated with outcome in locally advanced cervical cancer.

Schernberg A, Reuze S, Orlhac F, Buvat I, Dercle L, Sun R, Limkin E, Escande A, Haie-Meder C, Deutsch E, Chargari C, Robert C.

Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):187-195. doi: 10.1007/s00259-017-3824-z. Epub 2017 Sep 15.

PMID:
28916879
47.

Time dependent modulation of tumor radiosensitivity by a pan HDAC inhibitor: abexinostat.

Rivera S, Leteur C, Mégnin F, Law F, Martins I, Kloos I, Depil S, Modjtahedi N, Perfettini JL, Hennequin C, Deutsch E.

Oncotarget. 2017 Jan 25;8(34):56210-56227. doi: 10.18632/oncotarget.14813. eCollection 2017 Aug 22.

48.

A phase 1 dose-escalation study of the oral histone deacetylase inhibitor abexinostat in combination with standard hypofractionated radiotherapy in advanced solid tumors.

Deutsch E, Moyal EC, Gregorc V, Zucali PA, Menard J, Soria JC, Kloos I, Hsu J, Luan Y, Liu E, Vezan R, Graef T, Rivera S.

Oncotarget. 2016 Dec 24;8(34):56199-56209. doi: 10.18632/oncotarget.14147. eCollection 2017 Aug 22.

49.

[Doses to organs at risk in conformational and stereotactic body radiation therapy: Liver].

Debbi K, Janoray G, Scher N, Deutsch É, Mornex F.

Cancer Radiother. 2017 Oct;21(6-7):604-612. doi: 10.1016/j.canrad.2017.07.042. Review. French.

PMID:
28893525
50.

[Repair and time-dose factor: The example of spinal cord irradiation].

Chargari C, Maroun P, Louvel G, Drouet M, Riccobono D, François S, Dhermain F, Cosset JM, Deutsch É.

Cancer Radiother. 2017 Oct;21(6-7):547-553. doi: 10.1016/j.canrad.2017.07.039. Epub 2017 Sep 6. Review. French.

PMID:
28888745

Supplemental Content

Loading ...
Support Center